Dynavax Technologies Corp. (DVAX)
15.38
+0.01
(+0.07%)
USD |
NASDAQ |
Dec 31, 16:00
15.38
0.00 (0.00%)
After-Hours: 05:06
Dynavax Technologies Cash from Investing (Quarterly): 27.32M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Merck & Co., Inc. | -283.00M |
| Agios Pharmaceuticals, Inc. | 95.56M |
| Hyperion DeFi, Inc. | -20.11M |
| Edgewise Therapeutics, Inc. | 35.72M |
| Moderna, Inc. | 700.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 33.83M |
| Cash from Financing (Quarterly) | -0.061M |
| Free Cash Flow | 80.54M |
| Free Cash Flow Per Share (Quarterly) | 0.2388 |
| Free Cash Flow to Equity (Quarterly) | 32.93M |
| Free Cash Flow to Firm (Quarterly) | 34.15M |
| Free Cash Flow Yield | 3.79% |